The trial in numbers
12461 Patients randomised
525 Patients randomised in the Golden hour in 2018
539 Patients to recruit by 31 January 2019
Every minute counts
12,461 patients recruited
28 recruiting countries
171 hospitals and medical centres
ABOUT THE TRIAL
The CRASH3 trial aims to provide the research based information to prevent death by Traumatic Brain Injury.
The CRASH3 trial is testing whether tranexamic acid, a blood clot stabiliser that was discovered in Japan in the 1950’s, can become an essential tool for fighting excessive bleeding in the brain after Traumatic Brain Injury.more info
If you were a patient randomised into this trial and would like further information about your treatment, click below.
The staff at the hospital where you were being treated for your traumatic brain injury should have given you an information leaflet about the CRASH3 trial. If you have any questions or concerns about your treatment in the hospital, please contact your doctor in the first instance.more info